Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025 and Jan 2026.
- Largest single sale: $4.4M (9,532 shares) of Vertex Pharmaceuticals on Jan 6, 2026. Filing
- Last sale before this period: Mar 10, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| TJX Companies (TJX) | Director | Sep 22, 2023 | Jun 11, 2026 |
| Vertex Pharmaceuticals (VRTX) | EVP, Co & Fo | Apr 12, 2019 | Feb 26, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 24, 2026, Vertex Pharmaceuticals: 1,744 shares withheld by the company for taxes. 1 filing: 1
- Feb 17, 2026, Vertex Pharmaceuticals: 7,365 shares granted; 2,294 shares withheld by the company for taxes. 1 filing: 1
- Feb 13, 2026, Vertex Pharmaceuticals: 4,565 shares withheld by the company for taxes. 1 filing: 1
- Feb 10, 2026, Vertex Pharmaceuticals: 3,045 shares withheld by the company for taxes. 1 filing: 1
- Jan 22, 2026, Vertex Pharmaceuticals: 13,600 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.